Clinical Trial

Trial to Evaluate the Efficacy And Safety of IVIEW-1201 In the Treatment of Fungal Keratitis

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
A Phase II, Multi-center, Randomized, Masked, Parallel-Control Study to Evaluate the Clinical Efficacy and Safety of IVIEW-1201 (1.0% PVP-Iodine) Gel Forming Ophthalmic Solution in the Treatment of Fungal Keratitis.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-06-13; most recent amendment 2025-10-12.
Trial Details
NCT Number NCT06463678
Lead Sponsor IVIEW Therapeutics Inc.
Conditions Fungal Keratitis
Enrollment 60 participants
Start Date 2026-08-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-10-15